Immunosuppression: Learning from the masters

Expert Review of Clinical Immunology

Volumn 3, Issue 5, 2007, Pages 659-662

  Benedict, Chris A ^a   Janssen, Edith M ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CALCINEURIN INHIBITOR; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; CELL CYCLE ARREST; CELL DEATH; CELL INTERACTION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; DRUG RESEARCH; DRUG USE; EDITORIAL; ENZYME ACTIVATION; GRAFT REJECTION; GRAFT SURVIVAL; HERPES VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; NONHUMAN; ORGAN TRANSPLANTATION; PERSISTENT VIRUS INFECTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VIRUS LATENCY; VIRUS REPLICATION;

EID: 34648837310     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.3.5.659     Document Type: Editorial

References (26)

1. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. Viral subversion of the immune system. Ann. Rev. Immunol. 18, 861-926 (2000).
2. Brocchieri L, Kledal TN, Karlin S, Mocarski ES. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J. Virol. 79(12), 7570-7596 (2005).
3. Murphy E, Yu D, Grimwood J et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl Acad. Sci. USA 100(25), 14976-14981 (2003).
4. + T cells: lessons from cytomegalovirus. Viral Immunol. 18(3), 434-444 (2005).
5. Mocarski ES Jr. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell. Microbiol. 6(8), 707-717 (2004).
6. Thale R, Lucin P, Schneider K, Eggers M, Koszinowski UH. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68(12), 7757-7765 (1994).
7. Mintern JD, Klemm EJ, Wagner M et al. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus Fc receptor-1. J. Immunol. 177(12), 8422-8431 (2006).
8. Loewendorf A, Kruger C, Borst EM, Wagner M, Just U, Messerle M. Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J. Virol 78(23), 13062-13071 (2004).
9. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99(8), 2913-2921 (2002).
10. Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164(1), 144-151 (2000).
11. Boonen GJ, van Dijk AM, Verdonck LF, van Lier RA, Rijksen G, Medema RH. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kipl expression in human peripheral T lymphocytes. Euro. J. Immunol. 29(3), 789-798 (1999).
12. Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251 (4991), 313-316 (1991).
13. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2(11), 1077-1084 (2001).
14. Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15, 997-1009 (2001).
15. + T cell survival in HIV infection. J. Exp. Med. 203(10), 2281-2292 (2006).
16. Watanabe N, Gavrieli M, Sedy JR et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nature Immunol. 4(7), 670-679 (2003).
17. Han P, Goularte OD, Rufner K, Wilkinson B, Kaye J. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172(10), 5931-5939 (2004).
18. Sedy JR, Gavrieli M, Potter KG et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6(1), 90-98 (2005).
19. Montgomery RI, Warner MS, Lum B, Spear PG. Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427-436 (1996).
20. Lurain NS KK, Huang DD, Short JA et al. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage dinical isolates. J. Virol. 73(12), 10040-10050 (1999).
21. Benedict CA, Butrovich KD, Lurain NS et al. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J. Immunol. 162(12), 6967-6970 (1999).
22. Cheung TC, Humphreys IR, Potter KG et al. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc. Natl Acad. Sci. USA 102(37), 13218-13223 (2005).
23. Ware CF. Network communications: lymphotoxins, LIGHT, and TNE Ann. Rev. Immunol. 23, 787-819 (2005).
24. Lockridge KM, Zhou SS, Kravitz RH et al. Primate cytomegaloviruses encode and express an IL-10-1ike protein, Virology 268(2), 272-280 (2000).
25. Spencer JV, Lockridge KM, Barry PA et al. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76(3), 1285-1292 (2002).
26. Mellor A. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem. Biophys. Res. Comm. 338(1), 20-24 (2005 cia)